Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
20
CRIS Quote, Financials, Valuation and Earnings
Last price:
$1.77
Seasonality move
:
-5.84%
Day range:
$1.83 - $1.91
52-week range:
$1.02 - $8.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.15x
P/B ratio:
9.96x
Volume:
77.9K
Avg. volume:
152.6K
1-year change:
-72.25%
Market cap:
$19.3M
Revenue:
$10.9M
EPS (TTM):
-$6.23
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.8M | $10.6M | $10.2M | $10M | $10.9M | |
| Revenue Growth (YoY) | 8.31% | -1.72% | -4.57% | -1.37% | 8.83% | |
| Cost of Revenues | $534K | $533K | $257K | $212K | $98K | |
| Gross Profit | $10.3M | $10.1M | $9.9M | $9.8M | $10.8M | |
| Gross Profit Margin | 95.07% | 95% | 97.47% | 97.89% | 99.1% | |
| R&D Expenses | $23.1M | $34.9M | $43.3M | $39.5M | $38.6M | |
| Selling, General & Admin | $12.1M | $17.3M | $19.6M | $18.6M | $16.8M | |
| Other Inc / (Exp) | $22K | $890K | -- | -- | $1.2M | |
| Operating Expenses | $35.2M | $52.2M | $62.9M | $58.1M | $55.4M | |
| Operating Income | -$24.9M | -$42.1M | -$53M | -$48.3M | -$44.5M | |
| Net Interest Expenses | $5M | $4.3M | $3.7M | -- | -- | |
| EBT. Incl. Unusual Items | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | |
| Basic EPS (Cont. Ops) | -$12.20 | -$10.00 | -$12.14 | -$8.96 | -$6.88 | |
| Diluted EPS (Cont. Ops) | -$12.20 | -$10.00 | -$12.14 | -$8.96 | -$6.88 | |
| Weighted Average Basic Share | $2.4M | $4.6M | $4.7M | $5.3M | $6.3M | |
| Weighted Average Diluted Share | $2.4M | $4.6M | $4.7M | $5.3M | $6.3M | |
| EBITDA | -$24.7M | -$40.8M | -$51.7M | -$45.1M | -$42.6M | |
| EBIT | -$24.8M | -$41M | -$51.9M | -$45.4M | -$42.8M | |
| Revenue (Reported) | $10.8M | $10.6M | $10.2M | $10M | $10.9M | |
| Operating Income (Reported) | -$24.9M | -$42.1M | -$53M | -$48.3M | -$44.5M | |
| Operating Income (Adjusted) | -$24.8M | -$41M | -$51.9M | -$45.4M | -$42.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.1M | $2.3M | $2.1M | $2.4M | |
| Revenue Growth (YoY) | -19.2% | -6.03% | 11.67% | -9.19% | 14.09% | |
| Cost of Revenues | $109K | $82K | $24K | $47K | $14K | |
| Gross Profit | $2.1M | $2M | $2.3M | $2M | $2.4M | |
| Gross Profit Margin | 95.02% | 96.01% | 98.96% | 97.75% | 99.41% | |
| R&D Expenses | $6.8M | $11.4M | $9.1M | $9.6M | $8.5M | |
| Selling, General & Admin | $4.1M | $5.7M | $4.8M | $4.9M | $4M | |
| Other Inc / (Exp) | -- | -- | -$584K | $78K | -$552K | |
| Operating Expenses | $10.9M | $17.1M | $13.9M | $14.5M | $12.5M | |
| Operating Income | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Net Interest Expenses | $1.1M | $976K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Basic EPS (Cont. Ops) | -$2.20 | -$3.60 | -$2.39 | -$2.05 | -$1.25 | |
| Diluted EPS (Cont. Ops) | -$2.20 | -$3.60 | -$2.39 | -$2.05 | -$1.25 | |
| Weighted Average Basic Share | $4.6M | $4.6M | $4.8M | $5.8M | $8.5M | |
| Weighted Average Diluted Share | $4.6M | $4.6M | $4.8M | $5.8M | $8.5M | |
| EBITDA | -$8.7M | -$15M | -$11.6M | -$12.4M | -$10.1M | |
| EBIT | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Revenue (Reported) | $2.2M | $2.1M | $2.3M | $2.1M | $2.4M | |
| Operating Income (Reported) | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Operating Income (Adjusted) | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.3M | $10.5M | $10.4M | $9.8M | $11.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $518K | $506K | $199K | $235K | $65K | |
| Gross Profit | $9.8M | $10M | $10.2M | $9.6M | $11.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $22.4M | $39.6M | $41M | $40M | $37.5M | |
| Selling, General & Admin | $12.7M | $18.8M | $18.7M | $18.8M | $15.9M | |
| Other Inc / (Exp) | $1K | $890K | -$1.6M | -$1.2M | -$394K | |
| Operating Expenses | $35M | $58.4M | $59.7M | $58.8M | $53.4M | |
| Operating Income | -$25.2M | -$48.4M | -$49.5M | -$49.2M | -$42.2M | |
| Net Interest Expenses | $4.9M | $4.1M | $4.1M | -- | -- | |
| EBT. Incl. Unusual Items | -$30.1M | -$51.6M | -$52.1M | -$47.7M | -$42.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$30.1M | -$51.6M | -$52.1M | -$47.7M | -$42.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$30.1M | -$51.6M | -$52.1M | -$47.7M | -$42.1M | |
| Basic EPS (Cont. Ops) | -$10.00 | -$11.40 | -$11.02 | -$8.68 | -$6.23 | |
| Diluted EPS (Cont. Ops) | -$10.00 | -$11.40 | -$11.02 | -$8.68 | -$6.23 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$25M | -$47.1M | -$48M | -$46M | -$40.3M | |
| EBIT | -$25.2M | -$47.3M | -$48.2M | -$46.2M | -$40.5M | |
| Revenue (Reported) | $10.3M | $10.5M | $10.4M | $9.8M | $11.2M | |
| Operating Income (Reported) | -$25.2M | -$48.4M | -$49.5M | -$49.2M | -$42.2M | |
| Operating Income (Adjusted) | -$25.2M | -$47.3M | -$48.2M | -$46.2M | -$40.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2M | $2.1M | $2.3M | $2.1M | $2.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $109K | $82K | $24K | $47K | $14K | |
| Gross Profit | $2.1M | $2M | $2.3M | $2M | $2.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.8M | $11.4M | $9.1M | $9.6M | $8.5M | |
| Selling, General & Admin | $4.1M | $5.7M | $4.8M | $4.9M | $4M | |
| Other Inc / (Exp) | -- | -- | -$584K | $78K | -$552K | |
| Operating Expenses | $10.9M | $17.1M | $13.9M | $14.5M | $12.5M | |
| Operating Income | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Net Interest Expenses | $1.1M | $976K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Basic EPS (Cont. Ops) | -$2.20 | -$3.60 | -$2.39 | -$2.05 | -$1.25 | |
| Diluted EPS (Cont. Ops) | -$2.20 | -$3.60 | -$2.39 | -$2.05 | -$1.25 | |
| Weighted Average Basic Share | $4.6M | $4.6M | $4.8M | $5.8M | $8.5M | |
| Weighted Average Diluted Share | $4.6M | $4.6M | $4.8M | $5.8M | $8.5M | |
| EBITDA | -$8.7M | -$15M | -$11.6M | -$12.4M | -$10.1M | |
| EBIT | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Revenue (Reported) | $2.2M | $2.1M | $2.3M | $2.1M | $2.4M | |
| Operating Income (Reported) | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Operating Income (Adjusted) | -$8.8M | -$15.1M | -$11.6M | -$12.5M | -$10.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $129.6M | $40M | $19.7M | $26.7M | $20M | |
| Short Term Investments | $38.9M | $75.9M | $66M | $29.7M | -- | |
| Accounts Receivable, Net | $3M | $3.2M | $3M | $2.8M | $3.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2M | $3.3M | $3.5M | $1.8M | $3M | |
| Total Current Assets | $172.8M | $122.4M | $92.1M | $60.9M | $26.4M | |
| Property Plant And Equipment | $7.2M | $6.3M | $5.1M | $3.5M | $3.4M | |
| Long-Term Investments | $14.6M | $24M | -- | -- | -- | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $819K | $726K | $2.7M | $3.9M | $2.5M | |
| Total Assets | $204.4M | $162.3M | $108.8M | $77.3M | $41.3M | |
| Accounts Payable | $4.2M | $6.4M | $3.2M | $3.2M | $3M | |
| Accrued Expenses | $987K | $3.1M | $5.7M | $9M | $7.1M | |
| Current Portion Of Long-Term Debt | $557K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7M | $682K | $1.1M | $1.3M | $1.3M | |
| Other Current Liabilities | -- | -- | -- | $8.5M | $7.6M | |
| Total Current Liabilities | $10.1M | $13.4M | $10M | $22M | $19M | |
| Long-Term Debt | $334K | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $73.7M | $71.6M | $62.3M | $57.6M | $47.3M | |
| Common Stock | $915K | $916K | $48K | $59K | $85K | |
| Other Common Equity Adj | -$3K | -$109K | -$186K | $229K | -- | |
| Common Equity | $130.7M | $90.7M | $46.6M | $19.7M | -$6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $130.7M | $90.7M | $46.6M | $19.7M | -$6M | |
| Total Liabilities and Equity | $204.4M | $162.3M | $108.8M | $77.3M | $41.3M | |
| Cash and Short Terms | $168.5M | $115.9M | $85.6M | $56.3M | $20M | |
| Total Debt | $891K | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $111M | $18.5M | $31.7M | $30M | $20.3M | |
| Short Term Investments | $45.4M | $102.2M | $40.1M | $10.8M | -- | |
| Accounts Receivable, Net | $2.2M | $2.1M | $2.3M | $2.2M | $2.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.3M | $3.4M | $3.9M | $3.2M | $2.2M | |
| Total Current Assets | $161.9M | $126.1M | $78M | $46.1M | $24.8M | |
| Property Plant And Equipment | $7M | $4.9M | $4.7M | $3.1M | $3M | |
| Long-Term Investments | $11.9M | -- | -- | -- | -- | |
| Goodwill | $9M | $9M | $9M | $9M | $9M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $816K | $726K | $2.9M | $3.9M | $2.5M | |
| Total Assets | $190.6M | $140.7M | $94.5M | $62M | $39.3M | |
| Accounts Payable | $3.4M | $4.3M | $2.6M | $3.6M | $5.1M | |
| Accrued Expenses | $1.1M | $2.9M | $4.2M | $4.8M | $5.2M | |
| Current Portion Of Long-Term Debt | $891K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $609K | $824K | $1.2M | $1.3M | $1.3M | |
| Other Current Liabilities | -- | -- | -- | -- | $7.2M | |
| Total Current Liabilities | $7M | $9.7M | $8.1M | $11.3M | $20.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $68.7M | $64.8M | $58M | $52.6M | $45.9M | |
| Common Stock | $916K | $916K | $966K | $59K | $105K | |
| Other Common Equity Adj | -$9K | -$451K | $9K | $338K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121.9M | $76M | $36.6M | $9.5M | -$6.6M | |
| Total Liabilities and Equity | $190.6M | $140.7M | $94.5M | $62M | $39.3M | |
| Cash and Short Terms | $156.4M | $120.7M | $71.8M | $40.7M | $20.3M | |
| Total Debt | $891K | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$29.9M | -$45.4M | -$56.7M | -$47.4M | -$43.4M | |
| Depreciation & Amoritzation | $144K | $158K | $233K | $255K | $203K | |
| Stock-Based Compensation | $2.7M | $5.3M | $6.8M | $6M | $5.9M | |
| Change in Accounts Receivable | $201K | -$181K | $249K | $181K | -$555K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$25.7M | -$37.6M | -$54.3M | -$38.4M | -$39.6M | |
| Capital Expenditures | $677K | -- | $416K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$49M | -$47.9M | $33M | $37.8M | $29.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $891K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.1M | -$4.5M | -$5M | -$6.5M | -$8.6M | |
| Cash From Financing | $188.8M | -$4.2M | $867K | $7.6M | $3.4M | |
| Beginning Cash (CF) | $16.4M | $130.4M | $40.7M | $20.3M | $27.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $114M | -$89.7M | -$20.4M | $6.9M | -$6.7M | |
| Ending Cash (CF) | $130.4M | $40.7M | $20.3M | $27.2M | $20.5M | |
| Levered Free Cash Flow | -$26.4M | -$37.6M | -$54.8M | -$38.4M | -$39.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Depreciation & Amoritzation | $43K | $36K | $64K | $64K | $59K | |
| Stock-Based Compensation | $1.1M | $1.7M | $1.4M | $1.6M | $1.2M | |
| Change in Accounts Receivable | $860K | $1.2M | $661K | $640K | $1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$13.2M | -$16.8M | -$12.2M | -$13.2M | -$7.3M | |
| Capital Expenditures | -- | $11K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.1M | -$3.1M | $26.2M | $18.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -$1.6M | -$2M | -$2.4M | -$2.5M | |
| Cash From Financing | -$1.3M | -$1.6M | -$2M | -$2.4M | $7.5M | |
| Beginning Cash (CF) | $130.4M | $40.7M | $20.3M | $27.2M | $20.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$18.6M | -$21.5M | $12M | $3.3M | $285K | |
| Ending Cash (CF) | $111.8M | $19.2M | $32.3M | $30.5M | $20.8M | |
| Levered Free Cash Flow | -$13.2M | -$16.8M | -$12.2M | -$13.2M | -$7.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$30.1M | -$51.6M | -$52.1M | -$47.7M | -$42.1M | |
| Depreciation & Amoritzation | $162K | $151K | $261K | $255K | $198K | |
| Stock-Based Compensation | $3.2M | $5.9M | $6.4M | $6.2M | $5.5M | |
| Change in Accounts Receivable | $324K | $123K | -$254K | $160K | -$161K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$29.9M | -$41.3M | -$49.7M | -$39.5M | -$33.6M | |
| Capital Expenditures | $436K | $11K | $405K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$58M | -$46.9M | $62.3M | $30.5M | $10.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.8M | -$4.7M | -$5.3M | -$6.9M | -$8.6M | |
| Cash From Financing | $186.2M | -$4.5M | $509K | $7.2M | $13.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $98.3M | -$92.7M | $13.1M | -$1.8M | -$9.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$30.3M | -$41.3M | -$49.7M | -$39.5M | -$33.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.9M | -$16.1M | -$11.6M | -$11.9M | -$10.6M | |
| Depreciation & Amoritzation | $43K | $36K | $64K | $64K | $59K | |
| Stock-Based Compensation | $1.1M | $1.7M | $1.4M | $1.6M | $1.2M | |
| Change in Accounts Receivable | $860K | $1.2M | $661K | $640K | $1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$13.2M | -$16.8M | -$12.2M | -$13.2M | -$7.3M | |
| Capital Expenditures | -- | $11K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$4.1M | -$3.1M | $26.2M | $18.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.4M | -$1.6M | -$2M | -$2.4M | -$2.5M | |
| Cash From Financing | -$1.3M | -$1.6M | -$2M | -$2.4M | $7.5M | |
| Beginning Cash (CF) | $130.4M | $40.7M | $20.3M | $27.2M | $20.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$18.6M | -$21.5M | $12M | $3.3M | $285K | |
| Ending Cash (CF) | $111.8M | $19.2M | $32.3M | $30.5M | $20.8M | |
| Levered Free Cash Flow | -$13.2M | -$16.8M | -$12.2M | -$13.2M | -$7.3M | |
Get CRIS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRIS
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
9.96x
1.81x
Price / LTM sales
1.15x
1.67x
Growth Metrics
CRIS
Sector
Revenue growth
14.09%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
1.75%
8.01%
Earnings forecast
-$1.52
-$0.20
Profitability
CRIS
Sector
Profitability FY 2024
$10.8M
$47.5M
Return on invested capital
-461.34%
-16.26%
Return on assets
-89.45%
-13.27%
Return on equity
-461.34%
-18.61%
Earnings Date
Last Earnings Date
May
6
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Aug
5
Balance Sheet
CRIS
Sector
Total cash
$20.3M
$35.7M
Short term investments
--
$29.7M
Total assets
$41.3M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
